Recent Updates
Recently added Catalysts
IMNM Positive Sentiment

Immunome to Present at Upcoming Investor Conferences

Key Takeaway: Immunome, Inc. announced its participation in two upcoming investor conferences. The management team will present at the 9th Annual Evercore Healthcare Conference on December 1, 2026, and at the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026. This engagement highlights the company's focus on oncology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Immunome is actively engaging with investors.
  • The company is committed to developing innovative cancer therapies.
  • Management will present at two notable healthcare conferences.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+27%
120-day peak, hindsight
Typical move
28.8%
average across 3 past catalysts
Cash runway
~23 mo
Low dilution risk
Lead asset
IM-1021
Phase 1 · Solid Malignancies

Full Press Release Details

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class cancer therapies, today announced that members of the company’s management team will present at the following investor conferences: 9th Annual Evercore Healthcare Conference Presentation Date/Time: December 1, 2026, at 9:10 a.m. ET Piper Sandler 38th Annual Healthcare Conference Presentation Date/Time: December 2, 2026, at 10:30 a.m.

Frequently Asked Questions

When will Immunome present at the conferences?

Immunome will present on December 1 and 2, 2026.

Which conferences will Immunome attend?

Immunome will attend the Evercore and Piper Sandler conferences.

What is Immunome's focus?

Immunome focuses on developing cancer therapies.

What time is Immunome's presentation at Evercore?

The presentation at Evercore is at 9:10 a.m. ET.

Last updated: Nov 18, 2026